StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Feel bad for the poor souls

<< Previous

Bullboard Posts

Next >>

Comment by Liked2Thinkon Apr 05, 2021 1:33pm

99 Views

Post# 32937817

RE:Feel bad for the poor souls

haha yeah i did some more loading up on tuesday actually.

Did the same thing last quarter end and got burned then as well.

I obviously will never learn.

Im in panic mode now. Lost over 1/3 of my portfolio in 2 days.

I dont see the path back to $1.50 now. Aristotle wont do anything for Q1 results. Maybe something for Q2. Let say 3.2-3.5M made for Q1 but this isnt a covid company its a cancer company right.

This rollout I feel has done far more damage than it already appears to have done.

Im thinking 86 cents after tomorrow.

<< Previous

Bullboard Posts

Next >>

Options trading in a volatile macro environment